845626-36-0

Basic information

• Product Name: 3-benzyl-N,N-dimethyl-3-azabicyclo[3.1.0]hexan-6-amine
• Synonyms: 3-benzyl-N,N-dimethyl-3-azabicyclo[3.1.0]hexan-6-amine
• CAS NO: 845626-36-0
• Molecular Weight: 216.326
• Mol File: 845626-36-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-benzyl-N,N-dimethyl-3-azabicyclo[3.1.0]hexan-6-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-benzyl-N,N-dimethyl-3-azabicyclo[3.1.0]hexan-6-amine(845626-36-0)
• EPA Substance Registry System: 3-benzyl-N,N-dimethyl-3-azabicyclo[3.1.0]hexan-6-amine(845626-36-0)

Safety Data

• Hazardous Substances Data: 845626-36-0(Hazardous Substances Data)

Upstream product

• 50-00-0 formaldehyd 
• 151860-17-2 (1α,5α,6α)-3-N-benzyl-6-amino-3-aza-bicyclo[3.1.0]hexane 
• 64-18-6 formic acid 

Relevant articles and documents

AZABICYCLIC MUSCARINIC RECEPTOR ANTAGONISTS

The present invention generally relates to muscarinic receptor antagonists, which are useful for treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to processes for preparing compounds described herein, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.

Rifamycin analogs and uses thereof

The present invention features rifamycin analogs that can be used as therapeutics for treating or preventing a variety of microbial infections. In one form, the analogs are acetylated at the 25-position, as is rifamycin. In another form, the analogs are deacetylated at the 25-position. In yet other forms, benzoxazinorifamycin, benzthiazinorifamycin, and benzdiazinorifamycin analogs are derivatized at various positions of the benzene ring, including 3′-hydroxy analogs, 4′- and/or 6′ halo and/or alkoxy analogs, and various 5′ substituents that incorporate a cyclic amine moiety.